Updated recommendations on human papillomavirus (HPV) vaccines: HP40-157/1-2017E-PDF
9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations.
|Department/Agency||Public Health Agency of Canada. National Advisory Committee on Immunization.|
|Title||Updated recommendations on human papillomavirus (HPV) vaccines|
|Subtitle||9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations.|
|Other Language Editions||[French]|
|Electronic Document|| |
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact the authoring department to request a format other than those available.
We invite you to consult the Frequently Asked Questions page for additional information regarding the Archived Content notice.
Note: The URLs contained in this/these document(s) may no longer be functional
|Note||Issued also in French under title: Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : calendrier de vaccination du vaccin nonavalent contre le VPH à deux doses et utilisation des vaccins anti-VPH chez les populations immunodéprimées.|
|Number of Pages||29 p.|
|Departmental Catalogue Number||Pub.: 160301|
|Subject Terms||Sexually transmitted diseases, Immunization|
- Date modified: